Location: New York, NY
CIK: 0001839435 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $695M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 3,250,000 | $214M | 30.8% | $48.31 | +19.4% | COM | 03753U106 |
| — | CHINOOK THERAPEUTICS INC | 2,551,703 | $59.07M | 8.5% | $16.88 | — | COM | 16961L106 |
| — | VERONA PHARMA PLC | 2,468,000 | $49.56M | 7.1% | $17.59 | — | SPONSORED ADS | 925050106 |
| — | CYMABAY THERAPEUTICS INC | 4,570,918 | $39.86M | 5.7% | $7.72 | — | COM | 23257D103 |
| RCUS | ARCUS BIOSCIENCES INC | 2,172,000 | $39.62M | 5.7% | $33.27 | -42.6% | COM | 03969F109 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,185,000 | $30.15M | 4.3% | $25.79 | +24.3% | COM | 92790C104 |
| ROIV | ROIVANT SCIENCES LTD | 3,904,000 | $28.81M | 4.1% | $8.23 | 0.0% | SHS | G76279101 |
| — | MIRATI THERAPEUTICS INC | 750,000 | $27.89M | 4.0% | $52.54 | — | COM | 60468T105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 759,898 | $27.34M | 3.9% | $25.60 | +68.6% | COM NEW | 15117B202 |
| BBIO | BRIDGEBIO PHARMA INC | 1,338,160 | $22.19M | 3.2% | $30.51 | -61.8% | COM | 10806X102 |
| TNDM | TANDEM DIABETES CARE INC | 474,929 | $19.29M | 2.8% | $54.82 | -24.5% | COM NEW | 875372203 |
| — | AEROVATE THERAPEUTICS INC | 621,712 | $12.54M | 1.8% | $29.30 | — | COM | 008064107 |
| — | JASPER THERAPEUTICS INC | 6,382,500 | $11.55M | 1.7% | $1.81 | — | COM | 471871103 |
| TVTX | TRAVERE THERAPEUTICS INC | 495,000 | $11.13M | 1.6% | $21.26 | 0.0% | COM | 89422G107 |
| — | ALPINE IMMUNE SCIENCES INC | 1,202,000 | $9.279M | 1.3% | $7.20 | — | COM | 02083G100 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 499,996 | $8.595M | 1.2% | $30.23 | -35.7% | COM | 35104E100 |
| — | ITEOS THERAPEUTICS INC | 596,000 | $8.112M | 1.2% | $18.03 | — | COM | 46565G104 |
| DYN | DYNE THERAPEUTICS INC | 692,945 | $7.983M | 1.1% | $12.99 | 0.0% | COM | 26818M108 |
| XLO | XILIO THERAPEUTICS INC | 2,425,000 | $7.687M | 1.1% | $2.77 | +13.1% | COM | 98422T100 |
| VKTX | VIKING THERAPEUTICS INC | 375,000 | $6.244M | 0.9% | $4.46 | +131.4% | COM | 92686J106 |
| VERA | VERA THERAPEUTICS INC | 795,000 | $6.169M | 0.9% | $14.69 | -47.4% | CL A | 92337R101 |
| — | 89BIO INC | 400,000 | $6.092M | 0.9% | $12.86 | — | COM | 282559103 |
| RNAM | AVIDITY BIOSCIENCES INC | 382,000 | $5.864M | 0.8% | $26.66 | -17.5% | COM | 05370A108 |
| — | INTRA-CELLULAR THERAPIES INC | 94,700 | $5.128M | 0.7% | $46.53 | — | COM | 46116X101 |
| GERN | GERON CORP | 2,278,000 | $4.943M | 0.7% | $2.84 | 0.0% | COM | 374163103 |
| ACRS | ACLARIS THERAPEUTICS INC | 577,000 | $4.668M | 0.7% | $12.69 | 0.0% | COM | 00461U105 |
| ANNX | ANNEXON INC | 1,190,000 | $4.582M | 0.7% | $5.50 | 0.0% | COM | 03589W102 |
| — | GLYCOMIMETICS INC | 3,000,000 | $3.78M | 0.5% | $1.26 | — | COM | 38000Q102 |
| — | RENEO PHARMACEUTICALS INC | 420,000 | $2.512M | 0.4% | $5.98 | — | COM | 75974E103 |
| GOSS | GOSSAMER BIO INC | 1,958,069 | $2.467M | 0.4% | $9.60 | -80.1% | COM | 38341P102 |
| GPCR | STRUCTURE THERAPEUTICS INC | 93,692 | $2.229M | 0.3% | $23.79 | — | SPONSORED ADS | 86366E106 |
| BBIO | BRIDGEBIO PHARMA INC | 100,000 | $1.658M | 0.2% | $30.51 | -61.8% | Call | 10806X102 |
| STOK | STOKE THERAPEUTICS INC | 185,669 | $1.547M | 0.2% | $27.91 | -67.7% | COM | 86150R107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 396,000 | $1.525M | 0.2% | $3.85 | — | SPONSORED ADS | 152309100 |
| — | VECTIVBIO HLDG AG | 35,259 | $300K | 0.0% | $8.51 | — | ORD SHS | H9060V101 |
| — | PIERIS PHARMACEUTICALS INC | 301,490 | $294K | 0.0% | $0.98 | — | COM | 720795103 |